The del/del genotype of the nuclear factor-κB -94ATTG polymorphism and its relation to aggressive periodontitis

Journal of Periodontal Research

Volumn 45, Issue 3, 2010, Pages 396-403

  Schulz, S ^a   Hierse, L ^a   Altermann, W ^a   Klapproth, J ^a   Zimmermann, U ^a   Reichert, Y ^b   Glaser C ^a   Kluttig, A ^a   Stein, J M ^c   Schaller, H G ^a   Reichert, S ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Private Dental Department   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Bacterial occurrence; Nuclear factor B; Periodontitis; Polymorphism; Toll like receptor 2

Indexed keywords

ADENOSINE; ARGININE; GLUTAMINE; GUANINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THYMINE; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TRYPTOPHAN;

ADULT; AGE; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ARTICLE; BACTEROIDES; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; INDEL MUTATION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SMOKING; TOOTH PLAQUE; TREPONEMA DENTICOLA;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADENOSINE; ADULT; AGE FACTORS; AGGRESSIVE PERIODONTITIS; ARGININE; BACTEROIDES; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; GENETIC VARIATION; GENOTYPE; GLUTAMINE; GUANINE; HETEROZYGOTE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; SEQUENCE DELETION; SEX FACTORS; SMOKING; THYMINE; TOLL-LIKE RECEPTOR 2; TREPONEMA DENTICOLA; TRYPTOPHAN; AGGREGATIBACTER ACTINOMYCETEMCOMITANS;

EID: 77953173942     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01251.x     Document Type: Article

References (52)

1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999, 4:1-6.
2. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005, 76(suppl 11):2033-2041.
3. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008, 79(suppl 8):1569-1576.
4. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999, 45:7-17.
5. Ali S, Mann DA. Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair. Cell Biochem Funct 2004, 22:67-79.
6. Xu J, Wu HF, Ang ES. NF-kappaB modulators in osteolytic bone diseases. Cytokine Growth Factor Rev 2008, 20:7-17.
7. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol 2007, 22:145-151.
8. Bodet C, Chandad F, Grenier D. Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect 2006, 8:27-35.
9. Bodet C, Chandad F, Grenier D. [Pathogenic potential of Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, the red bacterial complex associated with periodontitis]. Pathol Biol (Paris) 2007, 4:154-162.
10. Brozovic S, Sahoo R, Barve S. Porphyromonas gingivalis enhances FasL expression via up-regulation of NFkappaB-mediated gene transcription and induces apoptotic cell death in human gingival epithzelial cells. Microbiology 2006, 3:797-806.
11. Tanabe S, Bodet C, Grenier D. Treponema denticola lipooligosaccharide activates gingival fibroblasts and upregulates inflammatory mediator production. J Cell Physiol 2008, 216:727-731.
12. Tanabe SI, Bodet C, Grenier D. Treponema denticola peptidoglycan induces the production of inflammatory mediators and matrix metalloproteinase 9 in macrophage-like cells. J Periodont Res 2008, 44:503-510.
13. Burns E, Bachrach G, Shapira L, Nussbaum G. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 2006, 177:8296-8300.
14. Beklen A, Hukkanen M, Richardson R, Konttinen YT. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 2008, 23:425-431.
15. Sugawara Y, Uehara A, Fujimoto Y. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 2006, 85:524-529.
16. Milward MR, Chapple IL, Wright HJ, Millard JL, Matthews JB, Cooper PR. Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol 2007, 148:307-324.
17. Folwaczny M, Glas J, Torok HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol 2004, 135:330-335.
18. Laine ML, Morre SA, Murillo LS, van Winkelhoff AJ, Pena AS. CD14 and TLR4 gene polymorphisms in adult periodontitis. J Dent Res 2005, 84:1042-1046.
19. Schroder NW, Meister D, Wolff V. Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes Immun 2005, 6:448-451.
20. Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005, 5:156-164.
21. Schulz S, Zissler N, Altermann W. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens. Int J Immunogenet 2008, 35:457-464.
22. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000, 68:6398-6401.
23. Kang TJ, Chae GT. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001, 31:53-58.
24. Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 2003, 170:3451-3454.
25. Gautam JK, Ashish, Comeau LD, Krueger JK, Smith MF. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling. J Biol Chem 2006, 281:30132-30142.
26. Emingil G, Berdeli A, Baylas H. Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis. J Periodontol 2007, 78:1968-1977.
27. Berdeli A, Emingil G, Han SB. TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population. J Clin Periodontol 2007, 34:551-557.
28. Zhu G, Li C, Cao Z, Corbet EF, Jin L. Toll-like receptors 2 and 4 gene polymorphisms in a Chinese population with periodontitis. Quintessence Int 2008, 39:217-226.
29. Karban AS, Okazaki T, Panhuysen CI. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004, 13:35-45.
30. Borm ME, van Bodegraven AA, Mulder CJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet 2005, 32:401-405.
31. Glas J, Torok HP, Tonenchi L. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm Bowel Dis 2006, 12:606-611.
32. Butt C, Sun S, Peddle L. Association of nuclear factor-kappaB in psoriatic arthritis. J Rheumatol 2005, 32:1742-1744.
33. Kim TH, Stone MA, Rahman P. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea. J Rheumatol 2005, 32:1907-1910.
34. Sun XF, Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 2007, 22:1387-1398.
35. Lewander A, Butchi AK, Gao J. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol 2007, 42:1332-1338.
36. Reichert S, Machulla HK, Klapproth J. Interferon-gamma and interleukin-12 gene polymorphisms and their relation to aggressive and chronic periodontitis and key periodontal pathogens. J Periodontol 2008, 79:1434-1443.
37. Epidemiology, etiology, prevention of periodontal diseases. World Health Organ Tech Rep Ser 1978, 621:1-60.
38. Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol 1980, 112:467-470.
39. Michalowicz BS, Diehl SR, Gunsolley JC. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 2000, 71:1699-1707.
40. Yoshie H, Kobayashi T, Tai H, Galicia JC. The role of genetic polymorphisms in periodontitis. Periodontol 2000 2007, 43:102-132.
41. Albandar JM. Epidemiology and risk factors of periodontal diseases. Dent Clin North Am 2005, 49:517-532.
42. Timmerman MF, Van der Weijden GA. Risk factors for periodontitis. Int J Dent Hyg 2006, 4:2-7.
43. Cortelli JR, Cortelli SC, Jordan S, Haraszthy VI, Zambon JJ. Prevalence of periodontal pathogens in Brazilians with aggressive or chronic periodontitis. J Clin Periodontol 2005, 32:860-866.
44. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005, 366:1809-1820.
45. Agerbaek MR, Lang NP, Persson GR. Microbiological composition associated with interleukin-1 gene polymorphism in subjects undergoing supportive periodontal therapy. J Periodontol 2006, 77:1397-1402.
46. Socransky SS, Haffajee AD, Smith C, Duff GW. Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol 2000, 27:810-818.
47. Schulz S, Machulla HK, Altermann W. Genetic markers of tumour necrosis factor alpha in aggressive and chronic periodontitis. J Clin Periodontol 2008, 35:493-500.
48. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, Heasman PA. The effect of smoking on periodontal treatment response: a review of clinical evidence. J Clin Periodontol 2006, 33:241-253.
49. Palmer RM. Should quit smoking interventions be the first part of initial periodontal therapy? J Clin Periodontol 2005, 32:867-868.
50. Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med 2005, 83:535-541.
51. Ogus AC, Yoldas B, Ozdemir T. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004, 23:219-223.
52. Soylu A, Kizildag S, Kavukcu S. TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch Schonlein purpura with and without renal involvement. Rheumatol Int 2009, 10.1007/s00296-009-1052.y, doi